Press Release Acurx Pharmaceuticals Receives FDA Conditional Acceptance and USPTO Trademark Allowance for the Company’s Brand Name for Ibezapolstat Aug 17
Press Release Acurx Pharmaceuticals, Inc. Reports Second Quarter 2026 results and provides business update Aug 14
Press Release Japan and Mexico Patent Offices Both Grant Acurx Pharmaceuticals New Patents for DNA Polymerase IIIC Inhibitor Antibiotics Aug 12